Bond Health vs Hippocratic AI and Grove AI

Why do sites choose Bond over Hippocratic AI and Grove AI?

• Patients come from your own charts. Bond screens the site's EHR against each study's criteria before anyone is contacted, reading clinical notes, prescriptions and lab results at more than 10,000 charts per hour, along with imaging data and other unstructured documents.^⁠[9],[12]
• Every match shows its evidence. Coordinators review ranked matches with the note, lab or medication behind each criterion decision, and Bond reports 50%+ less chart review and fewer screen failures.^⁠[9]
• Calls start from the chart. Bond's voice agents start from what Identify found in the chart, so they skip questions the chart already answers, can explain why the patient was contacted, and can pre-screen and book a visit in one conversation. They speak English, Spanish, Mandarin and many other languages, switch languages mid-call, and transfer live to a coordinator when the site wants that.^⁠[12]
• One platform from chart to consent and beyond. EHR screening, outreach, scheduling and consent support run in one workflow, with no data silos or manual handoffs from first match to signed consent.^⁠[9] After enrollment, the same agents send visit reminders, book transportation, collect symptoms and diaries, run side-effect check-ins and flag participants at risk of dropping out.^⁠[12]
• Connected to the systems sites run. Bond connects to all the major EHRs, including Epic, Oracle Health (Cerner), MEDITECH, athenahealth, eClinicalWorks, NextGen, Veradigm and OncoEMR, through FHIR and HL7, and is a CRIO Certified Partner.^⁠[9],[12]
• No integration fee. Bond charges a volume-based platform fee plus a success fee per randomized patient, with no integration fee. See pricing.^⁠[9],[12]
• Ads when you need more patients. For studies that need patients beyond your records, Bond sets up Meta and Google ad campaigns, and those leads flow into the same pre-screening and scheduling as EHR matches.^⁠[12]

How do Bond and Hippocratic AI compare, capability by capability?

Bond's column comes from Bond's website and product information. Hippocratic AI's column, which includes Grove AI, comes from Hippocratic AI's public pages and press coverage. "Not publicly documented" means we found no public description as of September 2026, not that the capability is absent.

Can Bond do what Hippocratic AI and Grove AI are known for?

Hippocratic AI and Grove AI promote phone pre-screening at volume, consent education, retention support, multilingual conversations and device-trial enrollment.^{⁠[3],[4],[1],[7]} Bond covers each one.

• Fast phone pre-screening. Bond's voice agents screened 1,000 patients in under 2 hours.^⁠[10] Its voice and SMS outreach has a 3x contact rate, and the agents can pre-screen and schedule a list the site already has, such as ad leads, referrals or registry contacts.^⁠[9]
• Consent education. Bond's consent support, with 90%+ completion, explains the consent form in plain language, answers patient questions and escalates to staff.^⁠[9] It checks the patient's understanding of key points and keeps an auditable record for the site.^⁠[12]
• Retention. After enrollment, the same voice and SMS agents send visit reminders, book transportation, collect symptoms and diaries, run side-effect check-ins and flag participants at risk of dropping out. Reminders can go by text, voice or email.^⁠[12]
• Many languages. Voice and text conversations and consent Q&A run in the patient's preferred language, including English, Spanish, Mandarin and many others, and can switch languages mid-call.^⁠[12]
• Device studies. Screening works for drug and device studies alike, because it is configured from each protocol's own criteria.^⁠[12]

Bond also hands patients to your team the way you choose: its agents transfer the call live to a coordinator or book a human callback, whichever the site prefers.^⁠[12]

How can you test Bond against Hippocratic AI on your own data?

Bond welcomes a head-to-head pilot. Give both vendors the same protocol and the same patient list under a business associate agreement, then compare evidence quality, contact rate, time to first visit and cost per randomized patient.

1. 1

   Use one protocol and one patient list

   Pick a study where coordinators already know who enrolled, who screen-failed and why, and give both vendors the same list.

2. 2

   Compare the evidence

   Ask each vendor to show why each patient qualifies. With EHR access, Bond shows the note, lab or medication behind each criterion decision.^⁠[9]

3. 3

   Compare contact rates

   Count the patients each vendor reaches and pre-screens, and review real transcripts, including requests for a human.

4. 4

   Measure time to first visit

   Track the time from list to first screening visit, along with show-ups and screen failures.

5. 5

   Compare cost per randomized patient

   Divide each vendor's total cost by the patients randomized. Bond charges its success fee per randomized patient; see pricing.^⁠[9]

Full EHR integration takes 48 hours, depending on the EHR, IT review and interface method, and Bond's implementation team handles it end to end, with no integration fee. Bond signs a BAA before any patient data is shared; see security.^⁠[9],[12] Bond can also share its technical report, a preprint with benchmark results on public datasets, on request.^⁠[11] Our vendor checklist for AI recruitment tools turns these steps into written questions.

How was this comparison made?

Bond Health wrote this page in September 2026. Facts about Hippocratic AI and Grove AI come only from their public web pages, press releases and press coverage, listed below with dates, not from private or internal competitive material. Grove AI's homepage now shows an acquisition notice, so Grove AI entries rely on the acquisition announcement and press coverage and may not match how Hippocratic AI offers Grace today.^⁠[8] Facts about Bond come from Bond's website, its presentation to the ACRP New Jersey chapter, its technical report and product information Bond provided.